Award
NIH Reporter #11387320
Reprograming CAR T cells by targeting IKZF-HDAC mediated chromatin remodeling to treat breast cancer
Recipient
Not Specified
Award Amount
$45,669.00
Ceiling
$45,669.00
Awarded
May 19, 2026
Identifier
11387320
Award for research on CAR T cell therapy targeting IKZF-HDAC mediated chromatin remodeling to treat breast cancer, funded by the National Cancer Institute with an award amount of $45,669.
Description
The project aims to investigate the epigenetic mechanisms involved in CAR T cell therapy for breast cancer. The research will be conducted at Northwestern University Feinberg School of Medicine and the Medical College of Wisconsin. The project includes multidisciplinary mentorship and training in immunology, oncology, and bioinformatics. The focus is on targeting IKZF-HDAC mediated chromatin remodeling to enhance CAR T cell efficacy.